dPCR Instrumentation represents an emerging segment with strong growth led by rising demand from early adopters. Continued technological advancements are expected to benefit demand for dPCR instrumentation in the near-to-mid term. dPCR is gaining popularity for its ability to take nucleic acid quantification and viral detection to the next level. Although dPCR outperforms qPCR in terms of precision, sensitivity, and specificity, qPCR is expected to hold its place in research and testing laboratories for the near term, complemented by dPCR systems. dPCR holds the potential to complement existing qPCR systems in addressing some of the technical challenges faced by virology researchers.
As stated by the new market research report on qPCR and dPCR Instrumentation, the United States represents the largest market worldwide. Japan continues to spearhead global growth with a projected compounded annual growth rate of 10.1% over the period. Education and Research constitutes the largest end-use segment for qPCR and dPCR instrumentation, while Testing Laboratories represents the fastest growing end-use segment.
Major players covered in the report include Agilent Technologies, Bio-Rad Laboratories Inc., Cepheid, Eppendorf AG, Exiqon A/S, F Hoffmann-La Roche Ltd., Fluidigm Corporation, Illumina Inc., Life Technologies Corporation, and RainDance Technologies Inc., among others.
The research report titled “qPCR and dPCR Instrumentation: A Global Strategic Business Report” announced by Global Industry Analysts Inc. provides a comprehensive review of market trends, drivers, challenges, mergers, ac
Copyright©2012 Vocus, Inc.
All rights reserved